Page last updated: 2024-08-22

azetidyl-2-carboxylic acid and Degenerative Diseases, Central Nervous System

azetidyl-2-carboxylic acid has been researched along with Degenerative Diseases, Central Nervous System in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abibi, A; Aguirre, AL; Bousquet, P; Gintant, G; Harris, CM; Hobson, AD; Kebede, T; Kim, Y; Konopacki, DB; Larson, K; Maull, JW; Moore, NS; Sarris, KK; Shi, D; Shrestha, A; Tang, X; Turner, SC; van der Kam, EL; Zhang, P	1

Other Studies

1 other study(ies) available for azetidyl-2-carboxylic acid and Degenerative Diseases, Central Nervous System

Article	Year
Discovery of A-971432, An Orally Bioavailable Selective Sphingosine-1-Phosphate Receptor 5 (S1P5) Agonist for the Potential Treatment of Neurodegenerative Disorders. Journal of medicinal chemistry, 2015, Dec-10, Volume: 58, Issue:23 Topics: Administration, Oral; Animals; Azetidinecarboxylic Acid; Benzene Derivatives; Blood-Brain Barrier; Cell Line; Cognitive Aging; Dogs; Female; Humans; Macaca fascicularis; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neurodegenerative Diseases; Rats; Rats, Sprague-Dawley; Receptors, Lysosphingolipid	2015

Article

Year

Discovery of A-971432, An Orally Bioavailable Selective Sphingosine-1-Phosphate Receptor 5 (S1P5) Agonist for the Potential Treatment of Neurodegenerative Disorders.

Journal of medicinal chemistry, 2015, Dec-10, Volume: 58, Issue:23

Topics: Administration, Oral; Animals; Azetidinecarboxylic Acid; Benzene Derivatives; Blood-Brain Barrier; Cell Line; Cognitive Aging; Dogs; Female; Humans; Macaca fascicularis; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neurodegenerative Diseases; Rats; Rats, Sprague-Dawley; Receptors, Lysosphingolipid

2015